Drug Shortage Report for DIPYRIDAMOLE INJECTION, USP
| Report ID | 103733 |
| Drug Identification Number | 02244475 |
| Brand name | DIPYRIDAMOLE INJECTION, USP |
| Common or Proper name | Dipyridamole Injection |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | DIPYRIDAMOLE |
| Strength(s) | 5MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS |
| Packaging size | 5 mg/mL 10 mL Vial |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-01-31 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2020-02-12 |
| Shortage status | Resolved |
| Updated date | 2020-02-13 |
| Company comments | This is a duplicate report. Actual shortage will be tracked under 104082 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2020-02-13 | English | Compare |
| v7 | 2020-02-12 | French | Compare |
| v6 | 2020-02-12 | English | Compare |
| v5 | 2020-02-12 | French | Compare |
| v4 | 2020-02-12 | English | Compare |
| v3 | 2020-02-01 | English | Compare |
| v2 | 2020-01-20 | French | Compare |
| v1 | 2020-01-20 | English | Compare |
Showing 1 to 8 of 8